Literature DB >> 17703008

Developing nurse prescribing in the UK.

Anthony J Avery, Veronica James.   

Abstract

Mesh：

Year:  2007        PMID： 17703008      PMCID： PMC1949441          DOI： 10.1136/bmj.39285.788808.3B

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Extended prescribing by UK nurses and pharmacists.

Authors:  Anthony J Avery; Mike Pringle
Journal:  BMJ       Date:  2005-11-19

2.  Prescribing trends by nurse practitioners and physician assistants in the United States.

Authors:  Daisha J Cipher; Roderick S Hooker; Patricia Guerra
Journal:  J Am Acad Nurse Pract       Date:  2006-06

3.  The use of cognitive continuum theory and patient scenarios to explore nurse prescribers' pharmacological knowledge and decision-making.

Authors:  Maxine Offredy; Sally Kendall; Claire Goodman
Journal:  Int J Nurs Stud       Date:  2007-03-23       Impact factor: 5.837
  3 in total
  4 in total

Review 1.  Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: a systematic review of literature.

Authors:  Sadiq Bhanbhro; Vari M Drennan; Robert Grant; Ruth Harris
Journal:  BMC Health Serv Res       Date:  2011-12-02       Impact factor: 2.655

2.  'Who does this patient belong to?' boundary work and the re/making of (NSTEMI) heart attack patients.

Authors:  Helen Cramer; Jacki Hughes; Rachel Johnson; Maggie Evans; Christi Deaton; Adam Timmis; Harry Hemingway; Gene Feder; Katie Featherstone
Journal:  Sociol Health Illn       Date:  2018-06-28

3.  The expansion of the role of nurse prescribing in intensive care units in the healthcare system of Iran: a qualitative content analysis.

Authors:  Azam Naderi; Abbas Abbaszadeh; Marzieh Pazokian; Camelia Rohani; Rostam Jalali
Journal:  J Med Life       Date:  2022-02

4.  Teaching clinical pharmacology and therapeutics with an emphasis on the therapeutic reasoning of undergraduate medical students.

Authors:  Milan C Richir; Jelle Tichelaar; Eric C T Geijteman; Theo P G M de Vries
Journal:  Eur J Clin Pharmacol       Date:  2008-01-29       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.